Trial reportLasers in medical science2026
The effect of photobiomodulation therapy on fatigue and behavioural status in patients with Hashimoto's thyroiditis.
Trial report in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe standard lifelong treatment for Hashimoto’s thyroiditis (HT), a chronic autoimmune disease, is levothyroxine (LT4) therapy. Despite LT4 replacement therapy, patients continue to experience persistent fatigue, deterioration in psychological and general well-being. Our study was conducted to investigate the effects of photobiomodulation therapy (PMBT) combined with LT4 replacement therapy on fatigue and behavioural status in patients with HT.
methodsSixty patients with HT were randomised to receive active or sham PMBT twice weekly for three weeks. Clinical evaluations of the participants were performed before and at the third months after treatment. Fatigue was assessed using the Fatigue Impact and Severity Scale, sleep quality and sleepiness using the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale, and behavioural status using the Beck Anxiety and Depression Inventory.
resultsAt the end of the treatment fatigue severity, sleep quality, daytime sleepiness and behavioural status were improved in both groups. In the between-group comparisons, all clinical symptom states showed a significant improvement in favour of the active group (p < 0.05).
conclusionsAs a result, we concluded that PMBT is an effective method to reduce clinical symptoms in patients with HT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.